Company Profile - Pulmatrix Inc

Introduction

Pulmatrix Inc (Pulmatrix) is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprietary dry powder delivery technology, iSPERSE. Its pipeline products include PUR1900, an anti-fungal compound which is in Phase 1 clinical trials intended to treat allergic bronchopulmonary aspergillosis in severe asthmatics and cystic fibrosis patients; PUR1800, a narrow-spectrum kinase inhibitor intended for the treatment of patients with chronic obstructive pulmonary disease (COPD); PUR3100, an formulation of DHE, intended to treat to orally inhaled acute migraine. Pulmatrix is headquartered in Lexington, Massachusetts, the US